Cro Splendid Lab Pvt. Ltd.

Zolmitriptan Impurities

Zolmitriptan is a member of the triptan class of 5-hydroxytryptamine(5-HT)1B/1D/(1F) receptor agonists used to treat acute migraine. Sumatriptan was the first triptan to be developed, but had poor oral bioavailability and lipophilicity. This led to the development of second-generation triptans, including almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, and zolmitriptan. Triptans can be administered alone or in combination with an NSAID like naproxen, and represent the current "gold standard" for acute migraine treatment. Zolmitriptan was first approved by the FDA for sale by Zeneca under the trade name Zomig® on November 25,
1997. It is currently available in both tablet and nasal spray forms. Zolmitriptan Impurities are primarily used as a reference standard in the pharmaceutical industry for analytical method development and validation to detect and quantify trace levels of this potential contaminant during the manufacturing process of the Zolmitriptan. It can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Zolmitriptan.

All impurities will be shared with all characterization data such as 1H NMR, 13C NMR, HPLC, MS, IR, TGA.

All Impurities are in stock with us.
Kindly share your enquiries at [email protected]

Anastrozole Impurities
Anastrozole was first approved for use in the United States in 1995. Anastrozole is a non-steroidal aromatase inhibitor (AI), similar to letrozole, used to decrease circulating estrogen levels in the treatment of postmenopausal women with estrogen-responsive breast cancer. Anastrozole is also related to exemestane, a steroidal AI, but its non-steroidal nature provides stark advantages including a lack of steroid-associated adverse effects such as weight gain and acne. Aromatase inhibitors, including anastrozole, have become endocrine drugs of choice in the treatment of postmenopausal breast cancer due to a more favorable efficacy and adverse effect profile as compared to earlier estrogen receptor modulators such as tamoxifen. Anastrozole Impurities are primarily used as a reference standard in the pharmaceutical industry for analytical method development and validation to detect and quantify trace levels of this potential contaminant during the manufacturing process of the Anastrozole. It can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Anastrozole.
All impurities will be shared with all characterization data such as 1H NMR, 13C NMR, HPLC, MS, IR, TGA.
All Impurities are in stock with us.
, , , CRO SPLENDID LAB PVT. LTD. Abhay Gandhi
Kindly share your enquiries at [email protected]